Clinical Practice Patterns in Hospitalized Patients at Risk for Invasive Candidiasis: Role of Antifungal Stewardship Programs in an Era of Rapid Diagnostics

Annals of Pharmacotherapy

Volumn 48, Issue 6, 2014, Pages 683-690

  Aitken, Samuel L ^a,b   Beyda, Nicholas D ^a   Shah, Dhara N ^a   Palmer, Hannah R ^b   Lasco, Todd M ^b   Koo, Hoonmo ^b,c   Garey, Kevin W ^a,b  

^a UNIVERSITY OF HOUSTON   (United States)

^b EAST TEXAS MEDICAL CENTER   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

antimicrobial stewardship; candidemia; fungemia; health care associated infections; prospective cohort study; rapid diagnostic tests

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ECHINOCANDIN; FLUCONAZOLE; MICAFUNGIN; PEPTIDE NUCLEIC ACID; ANTIFUNGAL AGENT;

ADULT; ANTIFUNGAL STEWARDSHIP PROGRAM; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BLOOD CULTURE; CANDIDA; CANDIDA ALBICANS; CANDIDEMIA; CANDIDURIA; CLINICAL PRACTICE; COHORT ANALYSIS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC TEST; DRUG COST; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FUNGUS IDENTIFICATION; HEALTH PROGRAM; HOSPITAL PATIENT; HUMAN; INCIDENCE; INFECTION RISK; INVASIVE CANDIDIASIS; MAJOR CLINICAL STUDY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MONTE CARLO METHOD; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RAPID DIAGNOSTIC TEST; SENSITIVITY AND SPECIFICITY; TERTIARY CARE CENTER; TREATMENT DURATION; AGED; CANDIDIASIS, INVASIVE; HOSPITALIZATION; ISOLATION AND PURIFICATION; MIDDLE AGED; RISK; STATISTICS AND NUMERICAL DATA;

ADULT; AGED; ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS, INVASIVE; DIAGNOSTIC TESTS, ROUTINE; ECHINOCANDINS; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PROSPECTIVE STUDIES; RISK;

EID: 84899757282     PISSN: 10600280     EISSN: 15426270     Source Type: Journal    
DOI: 10.1177/1060028014529928     Document Type: Article

References (32)

1. Wisplinghoff H,Bischoff T,Tallent SM,Seifert H,Wenzel RP,Edmond MB.Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study.Clin Infect Dis. 2004;39:309-317.
2. Garey KW,Rege M,Pai MP,et al.Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study.Clin Infect Dis. 2006;43:25-31.
3. Garey KW,Turpin RS,Bearden DT,Pai MP,Suda KJ.Economic analysis of inadequate fluconazole therapy in non-neutropenic patients with candidaemia: a multi-institutional study.Int J Antimicrob Agents. 2007;29:557-562.
4. Shah DN,Yau R,Weston J,et al.Evaluation of antifungal therapy in patients with candidaemia based on susceptibility testing results: implications for antimicrobial stewardship programmes.J Antimicrob Chemother. 2011;66:2146-2151.
5. Huang L,Zhang YY,Sun LY.Time to positivity of blood culture can predict different Candida species instead of pathogen concentration in candidemia.Eur J Clin Microbiol Infect Dis. 2013;32:917-922.
6. Horn DL,Neofytos D,Anaissie EJ,et al.Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.Clin Infect Dis. 2009;48:1695-1703.
7. Alexander BD,Johnson MD,Pfeiffer CD,et al.Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations.Clin Infect Dis. 2013;56:1724-1732.
8. Barnes RA.Early diagnosis of fungal infection in immunocompromised patients.J Antimicrob Chemother. 2008;61:i3-i6.
9. Clancy CJ,Nguyen MH.Finding the "missing 50%" of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care.Clin Infect Dis. 2013;56:1284-1292.
10. Ferroni A,Suarez S,Beretti JL,et al.Real-time identification of bacteria and Candida species in positive blood culture broths by matrix-assisted laser desorption ionization-time of flight mass spectrometry.J Clin Microbiol. 2010;48:1542-1548.
11. Neely LA,Audeh M,Phung NA,et al.T2 magnetic resonance enables nanoparticle-mediated rapid detection of candidemia in whole blood.Sci Transl Med. 2013;5:182ra54.
12. Beyda ND,Alam MJ,Garey KW.Comparison of the T2Dx instrument with T2Candida assay and automated blood culture in the detection of Candida species using seeded blood samples.Diagn Microbiol Infect Dis. 2013;77:324-326.
13. Lau A,Halliday C,Chen SC,Playford EG,Stanley K,Sorrell TC.Comparison of whole blood, serum, and plasma for early detection of candidemia by multiplex-tandem PCR.J Clin Microbiol. 2010;48:811-816.
14. Beyda ND,Chuang SH,Alam MJ,et al.Treatment of Candida famata bloodstream infections: case series and review of the literature.J Antimicrob Chemother. 2013;68:438-443.
15. Garey KW,Neuhauser MM,Bearden DT,et al.Evaluation of antifungals in the surgical intensive care unit: a multi-institutional study.Mycoses. 2006;49:226-231.
16. Pappas PG,Kauffman CA,Andes D,et al.Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.Clin Infect Dis. 2009;48:503-535.
17. Tam VH,Adams S,LaRocco MT,et al.An integrated pharmacoeconomic approach to antimicrobial formulary decision making.Am J Health Syst Pharm. 2006;63:735-739.
18. Yaman G,Akyar I,Can S.Evaluation of the MALDI TOF-MS method for identification of Candida strains isolated from blood cultures.Diagn Microbiol Infect Dis. 2012;73:65-67.
19. Hall L,Le Febre KM,Deml SM,Wohlfiel SL,Wengenack NL.Evaluation of the yeast traffic light PNA FISH probes for identification of Candida species from positive blood cultures.J Clin Microbiol. 2012;50:1446-1448.
20. Meersseman W,Lagrou K,Spriet I,et al.Significance of the isolation of Candida species from airway samples in critically ill patients: a prospective, autopsy study.Intensive Care Med. 2009;35:1526-1531.
21. Micafungin. RedBook Online [internet database]. Ann Arbor, MI: Truven Health Analytics; 2012. Accessed December 10, 2013. http://www-micromedexsolutions-com.ezproxyhost.library.tmc.edu/micromedex2/librarian/ND_T/evidencexpert/ND_PR/evidencexpert/CS/005498/ND_AppProduct/evidencexpert/DUPLICATIONSHIELDSYNC/F62E1E/ND_PG/evidencexpert/ND_B/evidencexpert/ND_P/evidencexpert/PFActionId/redbook.ShowProductSearchResults?SearchTerm=micafungin%20sodium&searchType=redbookGenericName&searchTermId=928384&searchContent=REDBOOK&searchFilterAD=filterADActive&searchFilterRepackager=filterExcludeRepackager&searchPattern=^micafungin.
22. Morrell M,Fraser VJ,Kollef MH.Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality.Antimicrob Agents Chemother. 2005;49:3640-3645.
23. Zilberberg MD,Kollef MH,Arnold H,et al.Inappropriate empiric antifungal therapy for candidemia in the ICU and hospital resource utilization: a retrospective cohort study.BMC Infect Dis. 2010;10:.
24. Arnold HM,Micek ST,Shorr AF,et al.Hospital resource utilization and costs of inappropriate treatment of candidemia.Pharmacotherapy. 2010;30:361-368.
25. Beyda ND,Lewis RE,Garey KW.Echinocandin resistance in Candida species: mechanisms of reduced susceptibility and therapeutic approaches.Ann Pharmacother. 2012;46 (7-8): 1086-1096.
26. Ananda-Rajah MR,Slavin MA,Thursky KT.The case for antifungal stewardship.Curr Opin Infect Dis. 2012;25:107-115.
27. Girao E,Levin AS,Basso M,et al.Seven-year trend analysis of nosocomial candidemia and antifungal (fluconazole and caspofungin) use in intensive care units at a Brazilian university hospital.Med Mycol. 2008;46:581-588.
28. Lai CC,Chu CC,Wang CY,et al.Association between incidence of candidaemia and consumption of antifungal agents at a medical centre in Taiwan.Int J Antimicrob Agents. 2012;40:349-353.
29. Forrest GN,Mankes K,Jabra-Rizk MA,et al.Peptide nucleic acid fluorescence in situ hybridization-based identification of Candida albicans and its impact on mortality and antifungal therapy costs.J Clin Microbiol. 2006;44:3381-3383.
30. Heil EL,Daniels LM,Long DM,Rodino KG,Weber DJ,Miller MB.Impact of a rapid peptide nucleic acid fluorescence in situ hybridization assay on treatment of Candida infections.Am J Health Syst Pharm. 2012;69:1910-1914.
31. Harris DM,Hata DJ.Rapid identification of bacteria and Candida using PNA-FISH from blood and peritoneal fluid cultures: a retrospective clinical study.Ann Clin Microbiol Antimicrob. 2013;12:.
32. Alexander BD,Ashley ED,Reller LB,Reed SD.Cost savings with implementation of PNA FISH testing for identification of Candida albicans in blood cultures.Diagn Microbiol Infect Dis. 2006;54:277-282.